What's new

Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised

Apr 3, 2025 - 13:49
 0
Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Why a small journal’s ‘blueprint for NIH’ may offer clues to the agency’s future

Next Article

Percy Pig’s US adventure may be short-lived as M&S respond to Trump tariffs

Related Posts

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Maximum residue limits (MRL)

Maximum residue limits (MRL)

Feb 18, 2025  0

Scientific and technical recommendations: Veterinary Medicines Regulation

Scientific and technical recommendations: Veterinary Me...

Apr 3, 2025  0